Aberdeen Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Sell |
37,188
-26,612
| -42% | -$168K | ﹤0.01% | 939 |
|
|
2025
Q1 | $409K | Hold |
63,800
| – | – | ﹤0.01% | 885 |
|
|
2024
Q4 | $513K | Hold |
63,800
| – | – | ﹤0.01% | 870 |
|
|
2024
Q3 | $806K | Hold |
63,800
| – | – | ﹤0.01% | 822 |
|
|
2024
Q2 | $808K | Hold |
63,800
| – | – | ﹤0.01% | 832 |
|
|
2024
Q1 | $305K | Hold |
63,800
| – | – | ﹤0.01% | 901 |
|
|
2023
Q4 | $306K | Buy |
+63,800
| New | +$306K | ﹤0.01% | 910 |
|
|
2022
Q2 | – | Sell |
-7,000
| Closed | -$519K | – | 975 |
|
|
2022
Q1 | $519K | Buy |
7,000
+2,272
| +48% | +$168K | ﹤0.01% | 895 |
|
|
2021
Q4 | $676K | Buy |
4,728
+41
| +0.9% | +$5.86K | ﹤0.01% | 932 |
|
|
2021
Q3 | $972K | Buy |
4,687
+2,961
| +172% | +$614K | ﹤0.01% | 891 |
|
|
2021
Q2 | $366K | Buy |
+1,726
| New | +$366K | ﹤0.01% | 967 |
|